Document Detail


Osteoporosis and osteopenia: implications for periodontal and implant therapy.
MedLine Citation:
PMID:  22507063     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
How does low bone mineral density alter treatment decisions? Osteoporosis and osteopenia are major health care issues that may impact on periodontal and implant therapy. Because of the prevalence of osteoporosis, understanding its etiology and the current treatment regimens for patients with low bone mineral density is essential for dental professionals. Millions of patients are now taking medications for the treatment of osteoporosis, and periodontists should be aware of the many medication options that are prescribed. The most frequently prescribed drugs are the bisphosphonates. It is important to be aware that bisphosphonates are not all the same, and patient responses to treatment may vary depending on which bisphosphonates they are taking. Due to recent concerns about bisphosphonate-induced osteonecrosis of the jaw, this paper provides guidance to help the clinician regarding decision-making about preventive and interventional dental treatment when their patient has been prescribed a bisphosphonate. An understanding of current bisphosphonates, their uses, their structural differences and their intended actions helps to improve clinical decision-making. Current knowledge regarding the effects of osteoporosis/osteopenia on periodontal diseases and alveolar bone loss is inconclusive. It is certainly clear that bisphosphonates are not indicated as an adjunctive treatment as part of periodontal therapy because of the risk of osteonecrosis. Regarding implant placement, there are no convincing data that dental implant placement is contraindicated in the osteoporotic patient. However, patients should understand the small risk of compromised bone healing following implant placement if the patient has been taking bisphosphonates. Due to the risks of osteonecrosis, dental clinicians should work closely with their medical colleagues prior to the physician prescribing oral bisphosphonates. Ideally, optimal periodontal and dental health should be established before the patient commences bisphosphonate therapy.
Authors:
Joan Otomo-Corgel
Related Documents :
22327673 - Intracranial pressure telemetry: first experience of an experimental in vivo study usin...
22640643 - Breast reconstruction in bilateral prophylactic mastectomy patients: factors that influ...
8526403 - Advantages and limits of in vivo screening tests.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Periodontology 2000     Volume:  59     ISSN:  1600-0757     ISO Abbreviation:  Periodontol. 2000     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-04-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9313276     Medline TA:  Periodontol 2000     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  111-39     Citation Subset:  D    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hierarchical decisions on teeth vs. implants in the periodontitis-susceptible patient: the modern di...
Next Document:  Utilizing collagen membranes for guided tissue regeneration-based root coverage.